Elevated Serum Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Could be Useful in Lung Cancer Diagnosis

Kemal, Yasemin; Yucel, Idris; Ekiz, Kubilay; Demirag, Guzin; Yilmaz, Bahiddin; Teker, Fatih; Ozdemir, Meltem

추천

검색

자료유형: 학술저널

저자정보: Kemal, Yasemin (Department of Medical Oncology, Faculty of Medicine, 19 Mayis Univercity) Yucel, Idris (Department of Medical Oncology, Faculty of Medicine, 19 Mayis Univercity) Ekiz, Kubilay (Department of Internal Medicine, Faculty of Medicine, 19 Mayis Univercity) Demirag, Guzin (Department of Medical Oncology, Faculty of Medicine, 19 Mayis Univercity) Yilmaz, Bahiddin (Department of Medical Oncology, Faculty of Medicine, 19 Mayis Univercity) Teker, Fatih (Department of Medical Oncology, Faculty of Medicine, 19 Mayis Univercity) Ozdemir, Meltem (Department of Internal Medicine, Faculty of Medicine, 19 Mayis Univercity)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제6호

발행연도: 2014.1

수록면: 2,651 - 2,654 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Lung cancer (LC) is still the primary cause of cancer deaths worldwide, and late diagnosis is a major obstacle to improving lung cancer outcomes. Recently, elevated preoperative or pretreatment neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and mean platelet volume (MPV) detected in peripheral blood were identified as independent prognostic factors associated with poor survival with various cancers, including colon cancer, esophageal cancer, gastric cancer and breast cancer. Objective: The aim of this study was to examine whether MPV, NLR and PLR could be useful inflammatory markers to differentiate lung cancer patients from healthy controls. An investigation was also made of the relationship between these markers and other prognostic factors and histopathological subgroups. Materials and Methods: Retrospectively eighty-one lung cancer patients and 81 age-sexes matched healthy subjects included into the study. Patients with hypertension, hematological and renal disease, heart failure, chronic infection, hepatic disorder and other cancer were excluded from the study. The preoperative or pretreatment blood count data was obtained from the recorded computerized database. Results: NLR and PLR values were significantly higher in the LC patients compared to the healthy subjects.( NLR: 4.42 vs 2.45 p=0.001, PLR: 245.1 vs 148.2 p=0.002) MPV values were similar in both groups (7.7 vs 7.8). No statistically significant relationship was determined between these markers (MPV, NLR and PLR) and histopathological subgroups and TNM stages. Conclusions: NLR and PLR can be useful biomarkers in LC patients before treatment. Larger prospective studies are required to confirm these findings.

#Lung cancer #platelets #neutrophils #lymphocytes #ratios

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요